Today, Anthony Fauci, MD, director of the National Institute of Allergy and Infectious Diseases, announced during a White House press briefing that the Biden administration is investing $3.2 billion in the research and development of oral antiviral therapies for COVID-19 and other viruses with limited treatments."Vaccines remain the centerpiece of our arsenal against COVID-19, but antivirals are an important complement to existing vaccines," Fauci said.Further, Fauci said, antivirals could play a role during the next pandemic. "There are few treatments that exist for many of the viruses that have pandemic potential," he said.During the briefing, Jeff Zients, the Biden administration's coronavirus czar, said America was entering a summer of